Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Agios Pharma (AGIO)

Tipranks - Tipranks - Tue Apr 7, 7:46AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK) and Agios Pharma (AGIO).

Easter Sale - 70% Off TipRanks

Merck & Company (MRK)

J.P. Morgan analyst Chris Schott maintained a Buy rating on Merck & Company today and set a price target of $135.00. The company’s shares closed last Thursday at $120.87.

According to TipRanks.com, Schott is a 4-star analyst with an average return of 5.1% and a 56.0% success rate. Schott covers the Healthcare sector, focusing on stocks such as Amneal Pharmaceuticals, Bristol-Myers Squibb, and Elanco Animal Health. ;'>

Currently, the analyst consensus on Merck & Company is a Moderate Buy with an average price target of $133.26, representing a 10.7% upside. In a report issued on March 24, BMO Capital also maintained a Buy rating on the stock with a $135.00 price target.

See today’s best-performing stocks on TipRanks >>

Agios Pharma (AGIO)

In a report released today, Tessa Romero from J.P. Morgan maintained a Hold rating on Agios Pharma, with a price target of $36.00. The company’s shares closed last Thursday at $35.20.

According to TipRanks.com, Romero is a 4-star analyst with an average return of 12.9% and a 46.7% success rate. Romero covers the Healthcare sector, focusing on stocks such as EyePoint Pharmaceuticals, ACADIA Pharmaceuticals, and Rocket Pharmaceuticals. ;'>

Currently, the analyst consensus on Agios Pharma is a Moderate Buy with an average price target of $40.33, representing a 18.7% upside. In a report issued on April 1, Goldman Sachs also maintained a Hold rating on the stock with a $32.00 price target.

Read More on MRK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).